Companies Cryptocurrencies
Centogene NV
Centogene NV
Exchange: NasdaqGM
IPO Date:
CEO: Prof. Arndt Rolfs
Diagnostics & Research Healthcare đź”—
  • CNTG
  • 1.46
  • 39539136
    market cap
  • -0.02999997
If you bought

shares of Centogene NV (CNTG) on
You would have made
Old Price $12 Current Price $12

Centogene NV is a commercial-stage company. The company focuses on transforming clinical, genetic and biochemical data into medical solutions for patients, physicians and pharmaceutical companies. The firm provides the full spectrum of methods and technology for human genetics analysis. The company develops a rare disease platform based on its real-world data repository with over 2.0 billion weighted data points from over 450,000 patients representing around 115 different, which includes epidemiologic, phenotypic and genetic data that reflects a global population, as well as a biobank of patients’ blood samples. In addition, it is active in the research and development products for human genetics. The firm operates in Germany and the United States.

Address: Am Strande 7 Rostock MECKLENBURG-VORPOMMERN 18055

Stay updated.